HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuo Umezawa Selected Research

tyrosyl-proline (Tyr-Pro)

8/2013Earthworm-derived pore-forming toxin lysenin and screening of its inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuo Umezawa Research Topics

Disease

62Neoplasms (Cancer)
12/2021 - 12/2003
20Inflammation (Inflammations)
01/2021 - 01/2007
14Neoplasm Metastasis (Metastasis)
12/2021 - 01/2005
9Fibrosis (Cirrhosis)
01/2019 - 04/2003
9T-Cell Leukemia (Leukemia, T Cell)
09/2013 - 07/2002
8Body Weight (Weight, Body)
06/2019 - 08/2005
8Colitis
04/2017 - 03/2012
7Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 12/2004
7Breast Neoplasms (Breast Cancer)
12/2020 - 03/2004
7Leukemia
12/2020 - 12/2002
7Necrosis
01/2020 - 06/2008
6Carcinogenesis
01/2018 - 03/2004
5Lung Neoplasms (Lung Cancer)
01/2022 - 12/2007
5Hepatocellular Carcinoma (Hepatoma)
01/2021 - 09/2006
5Adenocarcinoma
09/2015 - 01/2002
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2012 - 08/2005
4Atopic Dermatitis (Atopic Eczema)
01/2021 - 06/2017
4Prostatic Neoplasms (Prostate Cancer)
12/2020 - 01/2003
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2016 - 03/2012
4Hodgkin Disease (Hodgkin's Disease)
09/2015 - 09/2005
4Carcinoma (Carcinomatosis)
01/2015 - 10/2006
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2015 - 09/2010
3Multiple Myeloma
12/2020 - 03/2005
3Cholangiocarcinoma
12/2020 - 01/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 03/2015
3Glioblastoma (Glioblastoma Multiforme)
01/2019 - 01/2012
3Alcoholic Fatty Liver
01/2019 - 01/2017
3Diabetes Mellitus
04/2018 - 12/2004
3Bites and Stings (Sting)
12/2017 - 01/2015
3Urinary Bladder Neoplasms (Bladder Cancer)
04/2015 - 12/2003
3Lymphoma (Lymphomas)
09/2013 - 05/2006
3Osteosarcoma (Osteogenic Sarcoma)
05/2013 - 08/2007
3Melanoma (Melanoma, Malignant)
01/2013 - 01/2011
3Arthritis (Polyarthritis)
05/2012 - 01/2005
3Type 2 Diabetes Mellitus (MODY)
12/2009 - 10/2004
2Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2021 - 04/2018
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 05/2012
2Infections
01/2021 - 02/2011
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 08/2014
2Uveitis
01/2020 - 01/2016
2Anaplastic Thyroid Carcinoma
01/2019 - 11/2008
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2015 - 09/2005
2Adenocarcinoma of Lung
02/2014 - 02/2012
2Ischemia
11/2013 - 09/2008
2Hemolysis
08/2013 - 06/2012

Drug/Important Bio-Agent (IBA)

58NF-kappa B (NF-kB)IBA
02/2019 - 07/2002
47dehydroxymethylepoxyquinomicinIBA
12/2021 - 01/2003
17CytokinesIBA
01/2021 - 12/2003
16conophyllineIBA
01/2021 - 11/2003
11Transcription Factors (Transcription Factor)IBA
01/2018 - 08/2005
10Pharmaceutical PreparationsIBA
10/2021 - 02/2005
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 07/2002
10Proteins (Proteins, Gene)FDA Link
01/2016 - 07/2005
6Anti-Inflammatory Agents (Anti-Inflammatories)IBA
04/2021 - 12/2006
6Antineoplastic Agents (Antineoplastics)IBA
04/2021 - 10/2006
6AlkaloidsIBA
01/2021 - 09/2009
6InterleukinsIBA
01/2019 - 12/2007
6LigandsIBA
01/2019 - 12/2004
6Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2016 - 12/2007
5Biological ProductsIBA
01/2021 - 12/2002
5Messenger RNA (mRNA)IBA
01/2017 - 04/2010
5LipopolysaccharidesIBA
03/2016 - 09/2009
5DNA (Deoxyribonucleic Acid)IBA
04/2013 - 01/2003
4Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 11/2007
4ChemokinesIBA
01/2019 - 12/2007
3GemcitabineFDA Link
01/2021 - 04/2013
3Hormones (Hormone)IBA
12/2020 - 01/2003
3EndotoxinsIBA
01/2020 - 05/2012
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
07/2018 - 11/2008
33- ((dodecylthiocarbonyl)methyl)glutarimideIBA
01/2018 - 01/2012
3epoxyquinomicin CIBA
06/2017 - 04/2003
3Dextran SulfateIBA
04/2017 - 03/2016
3glutarimideIBA
04/2017 - 03/2016
3Carboxymethylcellulose Sodium (Polycell)FDA Link
04/2017 - 03/2016
3Retinaldehyde (Retinal)IBA
01/2016 - 09/2007
3Interleukin-6 (Interleukin 6)IBA
01/2016 - 08/2005
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2016 - 12/2007
3Therapeutic UsesIBA
04/2015 - 01/2005
3Adenosine Triphosphate (ATP)IBA
05/2014 - 11/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2011 - 12/2007
3CaspasesIBA
11/2007 - 10/2004
3Insulin (Novolin)FDA Link
04/2006 - 12/2004
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 02/2006
2Ointments (Pastes)IBA
01/2021 - 06/2019
2Glucose (Dextrose)FDA LinkGeneric
12/2020 - 09/2013
2Matrix Metalloproteinases (MMPs)IBA
01/2020 - 01/2017
2Peptides (Polypeptides)IBA
01/2020 - 08/2016
2Dinitrochlorobenzene (DNCB)IBA
06/2019 - 06/2017
2Interleukin-8 (Interleukin 8)IBA
01/2019 - 03/2018
2LectinsIBA
12/2018 - 01/2016
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
10/2016 - 01/2012
2Antivenins (Antivenoms)IBA
10/2016 - 01/2015
2AminesIBA
08/2016 - 02/2009
2Dextrans (Dextran)FDA Link
03/2016 - 03/2012
2Rhodopsin (Visual Purple)IBA
01/2016 - 01/2014
2Anaplastic Lymphoma KinaseIBA
09/2015 - 09/2005
2AntioxidantsIBA
12/2014 - 01/2011

Therapy/Procedure

22Therapeutics
01/2021 - 12/2004
11Drug Therapy (Chemotherapy)
04/2018 - 02/2005
2Transplantation
09/2013 - 09/2010